Please join our live webinar with Dr. Mark DeWitt, Postdoctoral Fellow at University of California, as he discusses the use of gene editing techniques for hematopoietic stem and progenitor cells (HSPCs).
Mark DeWitt, PhD
Project Scientist, Corn Lab
University of California, Berkeley
Live Webinar: CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells
Tuesday, June 12, 2018 | 9 AM PDT / 12 PM EDT
If you are unable to attend the live webinar, please register and we will send you a link to view the recording when it becomes available.
- Delivery of gene editing machinery to target cells
- Homology-directed repair for precise gene editing
- Culture conditions required for efficient editing
- Levels of correction needed for the treatment of monogenic disorders such as sickle cell disease
Mark DeWitt received his PhD in Biophysics from the University of California, Berkeley. He joined the IGI in Dr. Jacob Corn's lab as a Postdoctoral Fellow in September 2014. His postdoctoral research, on which this webinar is based, was devoted to developing methods to correct the sickle mutation in HSPCs using CRISPR-Cas9. He is now a project manager for a CIRM-funded translational project to translate these protocols into future therapies for patients with sickle cell disease.